Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
860.60
-29.90 (-3.36%)
At close: Mar 23, 2026
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
9.35M INR
Profits / Employee
1.77M INR
Market Cap
896.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Dec 31, 2022 | 23,000 | -743 | -3.13% |
| Sep 30, 2022 | 23,000 | - | - |
| Jun 30, 2022 | 23,000 | -1,412 | -5.78% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 19,620 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
| Ajanta Pharma | 9,628 |
Zydus Lifesciences News
- 2 days ago - Zydus launches Semaglutide Injection in reusable pen device in India - Business Upturn
- 4 days ago - Zydus launches Aerolife Mini to enhance inhaler use for asthma and COPD - Business Upturn
- 5 days ago - Zydus and Torrent Pharma partner to co-market Semaglutide Injection in India - Business Upturn
- 6 days ago - Zydus and Lupin sign agreement to co-market Semaglutide injection in India - Business Upturn
- 10 days ago - Zydus Lifesciences shares in focus today after receiving USFDA approval for Cevimeline Hydrochloride Capsules - Business Upturn
- 21 days ago - Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more - Business Upturn
- 23 days ago - Zydus Lifesciences secures USFDA final approvals for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg - Business Upturn
- 25 days ago - Zydus to launch semaglutide injection in India - The Times of India